Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 5, 2004

View Archived Issues

Oral tacrolimus shows promise in steroid-refractory ulcerative colitis

Boehringer Ingelheim scientists claim new antiproliferative agents

New nAChR ligands and their use described by Aventis and Targacept

Novel beta3-adrenoceptor agonists covered by Kissei patent

Non-hemolytic indolicidin-based antibiotics identified by Indian researchers

Optically active calcium antagonists and their use in hypertension and other disorders

New antiangiogenic kinase inhibitors discovered at Cellular Genomics

French team identifies new G-quadruplex-binding telomerase inhibitors

Santaris describes novel potent Bcl-2 inhibitor SPC-2004

ANG-704: A metabolically stable bioreductive prodrug of combretastatin A4

Multiple targets elucidated for anti-GI cancer agent HKH-40A

AP-23573 enters phase II study for bone and soft tissue sarcomas

Pierre Fabre to commercialize Olux in Europe

Enbrel approved in E.U. for psoriasis

Gilead Sciences and Genelabs collaborate in HCV

U.K. approval for QVAR in Easi-Breathe inhaler

GenPat77 and MedImmune sign agreement on novel therapeutic target

Approvable letter for SnET2 for AMD

Tarceva NDA accepted for priority review

Primovist completes European mutual recognition procedure

FDA approves Remicade as first-line therapy in moderate to severe RA

Kissei takes option to Japanese license for YSCMA

RTA-203: a new mammalian V-ATPase inhibitor in preclinical testing

Good pharmacokinetic profiles reported for single-dose and twice-daily LBM-415

A PABA combination regimen shows promise in refractory melanoma

New data on the bactericidal activity of RO-4908463

Abilify approved for acute bipolar mania

Doripenem shows good antibacterial activity against a large number of clinical isolates

Single oral doses of palosuran are reported safe in healthy volunteers

DA-9601 increases ghrelin, leptin in peptic ulcer models

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...